Why Are There So Many Missed Diagnoses in Celiac Disease?
Main Article Content
Abstract
Celiac Disease is a chronic, multisystemic, autoimmune-mediated, genetic disorder that is triggered by the ingestion of gluten. This condition only develops in individuals with a specific genetic predisposition (HLA-DQ2/HLA-DQ8 haplotypes). Gluten is a group of proteins found mainly in wheat, barley, and rye (and in some oat products due to cross-contamination), and its consumption provokes an abnormal immune response that damages the lining of the small intestine (1). This damage is characterized by atrophy of the intestinal villi—structures essential for nutrient absorption—leading to malabsorption and potentially resulting in nutritional deficiencies of varying severity which is characteristic, although not pathognomonic, ranging from an increase in intraepithelial lymphocytic infiltrate (ILEs) to total villous atrophy. Present a wide array of symptoms, affecting nearly every organ system (2,3).
At present, the only effective treatment is a strict and lifelong gluten-free diet, which can reverse inflammation, promote recovery of the intestinal mucosa, and prevent long-term complications. Comprehensive management also involves dietary education, clinical and nutritional follow-up, and monitoring for associated comorbidities(4). Given its impact on quality of life and the need for sustained adherence to treatment.
It is an emerging disease that represents a serious hidden public health problem worldwide, with high and increasing prevalence and healthcare costs (5,6). It has a global, homogeneous distribution, independent of race and age. The gender ratio is 2-3:1, with a higher incidence in women than in men.
There is written evidence of its existence dating back to the 2nd century BC, but it was only during World War II that gluten was identified as the toxin for these patients, leading to the adoption of a gluten-free diet.
We know that the number of missed diagnoses in celiac disease exceeds the number of confirmed cases. According to different authors, for every diagnosis that made, between three and ten cases remain undetected (with a global prevalence of approximately 1–2%) (2,3,7). We also know how important is an early diagnosis, because it helps prevent complications—many of them serious—and associated conditions that, in general, do not reverse after starting a gluten-free diet if treatment begins too late(8,9). When diagnoses are made in childhood and children adhere to a strict gluten-free diet, they typically do not develop complications or associated diseases later in life (2,10).
The aim of this communication is to analyze the main causes of underdiagnosis in celiac disease, raise awareness among healthcare professionals regarding non-classical clinical presentations, identify avoidable diagnostic errors, and promote increased clinical suspicion—particularly in at-risk populations—in order to shorten diagnostic delays and improve patient outcomes.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Lebwohl B, et al. Coeliac disease. Lancet. 2018;391(10115):70–81.
3. Al-Toma A, et al. ESsCD Guidelines for the diagnosis of coeliac disease in adults. United European Gastroenterol J. 2025.
4. Berkemeyer A. Understanding Celiac Disease for the General Pediatrician. Pediatric Annals. 2025; 54(8):e263-e268.
5. Leonard MM, et al. Celiac disease and nonceliac gluten sensitivity: a review. JAMA. 2017;318(7):647–656.
6. Rubio-Tapia A, et al. ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease (Update). Am J Gastroenterol. 2023;118(1):59–76.
7. Markharia GK et al. The global burden of coeliac disease: opportunities and challenges. Nat Rev Gastroenterol Hepatol. 2022;19(5):313-327.
8. Husby S, et al. ESPGHAN Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141–156.
9. Stahl MG, et al. Mass screening for celiac disease: the Autoimmunity Screening for Kids study. Am J Gastroenterol. 2021;116(1):180–187.
10. Green PHR, et al. Celiac disease and malignancy. Gastroenterology. 2019;156(1):56–66.
11. Zylberberg HM et al. Delay in Celiac Disease Diagnosis Among Patients with High-Risk Screening Conditions: Results from a United States. J. Clin. Med. 2025;14:6471.
12. Paez MA et al. Delay in Diagnosis of Celiac Disease in Patients Without Gastrointestinal Complaints. AJM 2017;130:1318-1323.
13. Lenti MV et al. Diagnostic delay in adult coeliac disease: An Italian multicentre study. Digestive and Liver Disease 2023;55(6):743-750.
14. Gatti S, et al. Global burden of celiac disease. Gastroenterology. 2024;167(1):23–33.
15. Bianchi PI et al. Diagnostic Delay of Celiac Disease in Childhood. JAMA 2024;7(4):e245671.
16. Leonard MM et al. AGA Clinical Practice Update on the Evaluation and Management of Seronegative Enteropathies: Expert Review. Gastroenterology 2021;160:437–444.
17. Blom J-J, et al. Diagnosis and management of celiac disease. CMAJ; 2025;197(38):E1258–E1265.
18. Syed S et al. Artificial Intelligence-Based Analytics for Diagnosis of Small Bowel Enteropathies and Black Box Feature Detection. J Pediatr Gastroenterol Nutr. 2021 June 01; 72(6): 833–841.
19. Ciacci C et al. Current Recommendations for Diagnosis of Celiac Disease. Gastrointest Endoscopy Clin N Am 2025;35:725–738.
20. Tovoli F, et al. Patchy villous atrophy and diagnostic pitfalls. Dig Liver Dis. 2019;51(3):430–435.
21. Lomash A et al. Coeliac disease presenting atypically: A much wider spectrum. Tropical Doctor. 2021 Jul 1;51(3):309-314.
22. Jaeckle F et al. Machine Learning Achieves Pathologist-Level Coeliac Disease Diagnosis. NEJM AI.; 2(4): doi:10.1056/AIoa2400738.
23. Villar-Balboa I et al. ICD-10-CM coding uncovers the gap between serological and clinically identified coeliac disease prevalence: A population-based study. European Journal of Internal Medicine 2025;138:52–59.
24. Casella E. Delay in the Diagnosis of Celiac Disease Today: An Underdiagnosed and Underestimated Disease. The European Society of Medicine Medical Research Archives 2025;13(7).
25. Bai J et al. Guía de práctica clínica sobre diagnóstico y tratamiento de la enfermedad celíaca en el primer nivel de atención. 2011 msal.gob.ar.
26. Moscatelli OG et al. Blood-based T-cell diagnosis of celiac disease. Gastroenterology 2025;169:1253-1267.
27. Leonard MM, et al. Emerging biomarkers and novel diagnostics in celiac disease. Gastroenterology. 2023;165(2):421–434.
28. Khawar Sana M, et al. Artificial intelligence in celiac disease. Computers in Biology and Medicine 2020;125:103996.
29. Ashley L et al. Celiac Disease: Navigating the Path to Diagnosis and Effective Management. Gastrointest Endoscopy Clin N Am 2025;35:xiii–xiv.
30. Chetcuti Zammit S et al. Quantification of Celiac Disease Severity Using Video Capsule Endoscopy: A Comparison of Human Experts and Machine Learning Algorithms. Current Medical Imaging, 2023;19:1455-1462.
31. Mascarenhas M et al. Artificial intelligence and capsule endoscopy: unravelling the future. Annals of Gastroenterology 2021;34:1-10.
32. Hartmann Toli I et al. Advancements in Computer-Aided Diagnosis of Celiac Disease: A Systematic Review. Biomimetics 2024;9:493.
33. Calleja S, et al. ITAMA project: addressing the submerged iceberg of celiac disease. Gastroenterol Insights. 2022;14(2):37.
http://orcid.org/0000-0002-0491-3902